Literature DB >> 23361976

A novel neurofibromin (NF1) interaction with the leucine-rich pentatricopeptide repeat motif-containing protein links neurofibromatosis type 1 and the French Canadian variant of Leigh's syndrome in a common molecular complex.

Vedant Arun1, Joseph C Wiley, Harpreet Kaur, David R Kaplan, Abhijit Guha.   

Abstract

Loss-of-function mutations and deletions in the neurofibromin tumor suppressor gene (NF1) cause neurofibromatosis type 1 (NF-1), the most common inherited syndrome of the nervous system in humans, with a birth incidence of 1:3,000. The most visible features of NF-1 are the neoplastic manifestations caused by the loss of Ras-GTPase-activating protein (Ras-GAP) activity mediated through the GAP-related domain (GRD) of neurofibromin (NF1), the protein encoded by NF1. However, the syndrome is also characterized by cognitive dysfunction and a number of developmental abnormalities. The molecular etiology of many of these nonneoplastic phenotypes remains unknown. Here we show that the tubulin-binding domain (TBD) of NF1 is a binding partner of the leucine-rich pentatricopeptide repeat motif-containing (LRPPRC) protein. These two proteins complex with Kinesin 5B, hnRNP A2, Staufen1, and Myelin Basic Protein (MBP) mRNA, likely in RNA granules. This interaction is of interest in that it links NF-1 with Leigh's syndrome, French Canadian variant (LSFC), an autosomal recessive neurodegenerative disorder that arises from mutations in the LRPPRC gene. Our findings provide clues to how loss or mutation of NF1 and LRPPRC may contribute to the manifestations of NF-1 and LSFC.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23361976     DOI: 10.1002/jnr.23189

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  8 in total

Review 1.  Ras-Specific GTPase-Activating Proteins-Structures, Mechanisms, and Interactions.

Authors:  Klaus Scheffzek; Giridhar Shivalingaiah
Journal:  Cold Spring Harb Perspect Med       Date:  2019-03-01       Impact factor: 6.915

Review 2.  Neurofibromin and suppression of tumorigenesis: beyond the GAP.

Authors:  Juan Mo; Stefanie L Moye; Renee M McKay; Lu Q Le
Journal:  Oncogene       Date:  2022-01-23       Impact factor: 8.756

3.  Neurofibromatosis Type 1: A Novel NF1 Mutation Associated with Mitochondrial Complex I Deficiency.

Authors:  Sara Domingues; Lara Isidoro; Dalila Rocha; Jorge Sales Marques
Journal:  Case Rep Genet       Date:  2014-03-04

4.  Evidence for differential alternative splicing in blood of young boys with autism spectrum disorders.

Authors:  Boryana S Stamova; Yingfang Tian; Christine W Nordahl; Mark D Shen; Sally Rogers; David G Amaral; Frank R Sharp
Journal:  Mol Autism       Date:  2013-09-04       Impact factor: 7.509

Review 5.  The Ras Superfamily of Small GTPases in Non-neoplastic Cerebral Diseases.

Authors:  Liang Qu; Chao Pan; Shi-Ming He; Bing Lang; Guo-Dong Gao; Xue-Lian Wang; Yuan Wang
Journal:  Front Mol Neurosci       Date:  2019-05-21       Impact factor: 5.639

6.  LRPPRC: A Multifunctional Protein Involved in Energy Metabolism and Human Disease.

Authors:  Jie Cui; Li Wang; Xiaoyue Ren; Yamin Zhang; Hongyi Zhang
Journal:  Front Physiol       Date:  2019-05-24       Impact factor: 4.566

Review 7.  Human pentatricopeptide proteins: only a few and what do they do?

Authors:  Robert N Lightowlers; Zofia M A Chrzanowska-Lightowlers
Journal:  RNA Biol       Date:  2013-04-23       Impact factor: 4.652

Review 8.  Neurofibromin Structure, Functions and Regulation.

Authors:  Mohammed Bergoug; Michel Doudeau; Fabienne Godin; Christine Mosrin; Béatrice Vallée; Hélène Bénédetti
Journal:  Cells       Date:  2020-10-27       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.